Almost at the end of the year 2014, the FDA announced approval of Novo nordisk's Saxenda(liraglutide), a powerful new injectable weight loss drug in addition to diet and exercise to fight the obesity epidemic. Saxenda has the same active ingredient as the diabetes medication Victoza although at a higher dosage of 3.0 mg instead of 1.2 mg or 1.8 mg in Victoza. Saxenda is the 2 nd weight loss drug to be approved in 2014 by the US FDA after Takeida pharmaceuticals Contrave was approved a few months prior and fourth weight loss drug to be approved since June of 2012 when Arena Pharmaceuticals Belviq and Orexigen's Qsymia were approved. 1. What do you need to know about Saxenda for weight loss? Saxenda® (liraglutide 3 mg) is new class of medications to be considered for weight loss - a class of drugs known as incretins. Containing glucagon-like peptide-1 (GLP-1) analogue with 97% similarity to naturally occurring human GLP-1, incretins contain an anologue similar
The FDA, after a long hiatus of over 10 years, approved two new weight loss medications in mid 2012, Lorcaserin (marketed as Belviq) and Phentermine and Topiramate (marketed as Qsymia). As it has been on the market for over two years, you may want to hear from physicians who are experienced in prescribing these and other weight loss medications. Many people trying to lose weight have a lot of questions and the internet has a lot of confusing information from all kinds of people. As a practicing weight loss physician, and founder of W8MD Medical Weight Loss Centers of America, here are some of the insights on these weight loss medications. The best weight loss medication on the market for fast and effective weight loss currently might be not a single medication but a combination of a few of these as may be appropriate in the individual patient. As there are over 50 different neurochemicals that affect the appetite center in the hypothalamus part of the brain, targeting just one